Organism: Homo sapiens
Gene: 38501_s_at
Selected probe(set): 205176_s_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 38501_s_at (205176_s_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):2.7277117
Number of Samples:24 / 3

Experimental	colorectal cancer study 4 (recurring)
	LCM-tumor tissue samples of patients who received resection after diagnosis of primary colorectal cancer. Patients developed metastatic recurrence during follow-up after surgery.
Control	adjacent colon tissue (recurring)
	Histologically normal colon tissue samples from patients with primary colorectal cancer collected after resection. Tissue was further extracted using laser-capture microdissection (LCM). With metastatic recurrence after resection during follow-up.

Relative Expression (log2-ratio):-2.6682749
Number of Samples:2 / 2

Experimental	doxorubicin study 3
	MCF7 cells treated with 2uM doxorubicin for 24 hours. ATC code:
Control	untreated MCF-7 cell sample
	MCF-7 cells untreated.

Relative Expression (log2-ratio):2.6594696
Number of Samples:3 / 3

Experimental	glioma study 17 (glioblastoma; A2B5+)
	Oligodendrocyte progenitor cells (OPC) isolated from high grade glioblastoma (grade IV). OPC were isolated using magnetic-activated cell sorting (MACS) with antibodies against A2B5 antigen. Patients were 66 ± 5 years old males.
Control	non-tumor oligodendrocyte progenitor cell sample (cortex)
	Oligodendrocyte progenitor cells (OPC) isolated from cortical tissue, which was obtained from patients with epilepsy, but without any manifested brain cancer. OPC were isolated using magnetic-activated cell sorting (MACS) with antibodies against A2B5 antigen.

Relative Expression (log2-ratio):-2.6268024
Number of Samples:6 / 6

Experimental	MAPK1 depletion study 1
	RNAi-mediated gene knockdown of MAPK1 in colorectal cancer cell line SW-480.
Control	control vector transfected SW-480 cell sample
	SW-480 colorectal cell line sample transduced with empty vector pLKO.

Relative Expression (log2-ratio):-2.4474764
Number of Samples:6 / 6

Experimental	MAPK1 depletion study 1
	RNAi-mediated gene knockdown of MAPK1 in colorectal cancer cell line SW-480.
Control	mock transfected SW-480 cell sample
	SW-480 colorectal cell line sample transduced with non-targeting pLKO_NonTarget vector.

Relative Expression (log2-ratio):-2.4299078
Number of Samples:4 / 2

Experimental	renal cell carcinoma study 6 (chromophobe type)
	Tumor tissue samples from the kidney of patients with chromophobe renal cell carcinoma (cRCC).
Control	normal kidney tissue (fetal)
	Normal fetal kidney tissue samples.

Relative Expression (log2-ratio):2.3608599
Number of Samples:23 / 4

Experimental	colorectal cancer study 4 (metastatic progression)
	LCM-tumor tissue samples of patients who received resection after diagnosis of primary colorectal cancer with metastatic progression.
Control	adjacent colon tissue (metastatic progression)
	Histologically normal colon tissue samples from patients with primary colorectal cancer and metastatic progression collected after resection. Tissue was further extracted using laser-capture microdissection (LCM).

Relative Expression (log2-ratio):2.3515005
Number of Samples:76 / 18

Experimental	colorectal cancer study 4 (non-recurring)
	LCM-tumor tissue samples of patients who received resection after diagnosis of primary colorectal cancer. Patients did not develop metastatic recurrence during follow-up after surgery.
Control	adjacent colon tissue (non-recurring)
	Histologically normal colon tissue samples from patients with primary colorectal cancer collected after resection. Tissue was further extracted using laser-capture microdissection (LCM). No metastatic recurrence during follow-up.

Relative Expression (log2-ratio):2.317812
Number of Samples:2 / 4

Experimental	glioma study 17 ( small cell glioblastoma; unsorted)
	Brain cells isolated from high grade small cell glioblastoma (grade IV). Tumor tissue was dissociated using enzymatic treatment and all cells were used for RNA isolation. Patients were 56 ± 3 years old males.
Control	non-tumor cortical tissue
	Cortical tissue obtained from patients with epilepsy, but without any manifested brain cancer. The tissue was dissociated using enzymatic treatment, but all brain cell types were used for analyses.

Relative Expression (log2-ratio):-2.2505808
Number of Samples:3 / 6

Experimental	stem cell differentiation study 47 (BMP-2; TGFb; 1d)
	Bone marrow-derived mesenchymal stem cell line (MSC) differentiated for 24 hours in the presence of bone morphogenetic protein 2 (BMP-2, 50ng/ml) and transforming growth factor beta (TGFb, 5 ng/ml). Cells were propagated for not more than five passages in mesenchymal stem cell growth medium, at 37 °C and in a humidified atmosphere containing 7.5 % CO2. MSCs were incubated for 24 hours in proliferation medium (PM, high glucose DMEM, 10 % FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin). Subsequently PMCs were differentiated for 24 hours in differentiation medium (consisting of PM with 10EXP(-6)M dexamethasone, 10 μg/ml insulin, 10EXP(-7) M rosiglitazone, 50 ng/ml BMP-2, 5 ng/ml TGFb), and harvested. Samples are biological replicates. Normal bone marrow was obtained from 3 healthy donors (5F0138, 6F4085, 7F3458).
Control	stem cell differentiation study 47 (0d)
	Undifferentiated bone marrow-derived mesenchymal stem cell line (MSC) without any treatment. Cells were propagated for not more than five passages in mesenchymal stem cell growth medium, at 37 °C and in a humidified atmosphere containing 7.5 % CO2. MSCs were incubated for 24 hours in proliferation medium (high glucose DMEM, 10 % FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin) and harvested. Samples are biological replicates. Normal bone marrow was obtained from 3 healthy donors (5F0138, 6F4085, 7F3458).